Institute of Immunology, Christian-Albrechts-University of Kiel, University Hospital Schleswig-Holstein, Kiel, Germany.
Clinical Research Development Laboratory, Department of Medicine, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
Front Immunol. 2019 Jul 18;10:1690. doi: 10.3389/fimmu.2019.01690. eCollection 2019.
Apart from their activity in combating infections, neutrophils play an important role in regulating the tumor microenvironment. Neutrophils can directly kill (antibody-coated) cancer cells, and support other immune anti-tumoral strategies. On the other hand, neutrophils can also exert pro-tumorigenic activities the production of factors which promote cancer growth, angiogenesis and metastasis formation. The balance of anti- and pro-cancer activity is influenced by the particularly delicate interplay that exists between neutrophils and T lymphocytes. In murine models, it has been reported that γδ T cells are a major source of IL-17 that drives the recruitment and pro-tumorigenic differentiation of neutrophils. This, however, contrasts with the well-studied anti-tumor activity of γδ T cells in experimental models and the anti-tumor activity of human γδ T cells. In this article, we first review the reciprocal interactions between neutrophils, tumor cells and T lymphocytes with a special focus on their interplay with γδ T cells, followed by the presentation of our own recent results. We have previously shown that zoledronic acid (ZOL)-activated neutrophils inhibit γδ T-cell proliferation due to the production of reactive oxygen species, arginase-1 and serine proteases. We now demonstrate that killing of ductal pancreatic adenocarcinoma (PDAC) cells by freshly isolated resting human γδ T cells was reduced in the presence of neutrophils and even more pronounced so after activation of neutrophils with ZOL. In contrast, direct T-cell receptor-dependent activation by γδ T cell-specific pyrophosphate antigens or by bispecific antibodies enhanced the cytotoxic activity and cytokine/granzyme B production of resting human γδ T cells, thereby overriding the suppression by ZOL-activated neutrophils. Additionally, the coculture of purified neutrophils with autologous short-term expanded γδ T cells enhanced rather than inhibited γδ T-cell cytotoxicity against PDAC cells. Purified neutrophils alone also exerted a small but reproducible lysis of PDAC cells which was further enhanced in the presence of γδ T cells. The latter set-up was associated with improved granzyme B and IFN-γ release which was further increased in the presence of ZOL. Our present results demonstrate that the presence of neutrophils can enhance the killing capacity of activated γδ T cells. We discuss these results in the broader context of regulatory interactions between neutrophils and T lymphocytes.
除了在抗感染方面的作用外,中性粒细胞在调节肿瘤微环境方面也发挥着重要作用。中性粒细胞可以直接杀死(抗体包被的)癌细胞,并支持其他免疫抗肿瘤策略。另一方面,中性粒细胞也可以发挥促肿瘤作用,产生促进癌症生长、血管生成和转移形成的因子。抗癌和致癌活性的平衡受到中性粒细胞和 T 淋巴细胞之间存在的特别微妙相互作用的影响。在小鼠模型中,已经报道 γδ T 细胞是驱动中性粒细胞募集和促肿瘤分化的 IL-17 的主要来源。然而,这与 γδ T 细胞在实验模型中的抗肿瘤活性以及人类 γδ T 细胞的抗肿瘤活性形成鲜明对比。在本文中,我们首先回顾了中性粒细胞、肿瘤细胞和 T 淋巴细胞之间的相互作用,特别关注它们与 γδ T 细胞的相互作用,然后介绍了我们自己的最新结果。我们之前已经表明,唑来膦酸(ZOL)激活的中性粒细胞由于产生活性氧、精氨酸酶-1 和丝氨酸蛋白酶而抑制 γδ T 细胞的增殖。我们现在证明,在存在中性粒细胞的情况下,新鲜分离的静息人类 γδ T 细胞对胰腺导管腺癌(PDAC)细胞的杀伤作用降低,而在用 ZOL 激活中性粒细胞后则更为明显。相比之下,通过 γδ T 细胞特异性焦磷酸盐抗原或双特异性抗体直接 T 细胞受体依赖性激活增强了静息人类 γδ T 细胞的细胞毒性活性和细胞因子/颗粒酶 B 产生,从而克服了 ZOL 激活的中性粒细胞的抑制作用。此外,纯化的中性粒细胞与自体短期扩增的 γδ T 细胞的共培养增强而不是抑制了 γδ T 细胞对 PDAC 细胞的细胞毒性。单独的纯化中性粒细胞本身也对 PDAC 细胞产生了小但可重复的溶解作用,而在存在 γδ T 细胞的情况下则进一步增强。在后一种设置中,颗粒酶 B 和 IFN-γ 的释放得到改善,而在存在 ZOL 的情况下进一步增加。我们目前的结果表明,中性粒细胞的存在可以增强激活的 γδ T 细胞的杀伤能力。我们在中性粒细胞和 T 淋巴细胞之间的调节相互作用的更广泛背景下讨论这些结果。